Biohit Oyj B
Research Biohit Oyj B (BIOBV) on Bullrun: market cap EUR 37.56M, P/E 13.7. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerBIOBV
- ExchangeHE
- CountryFinland
- SectorHealthcare
- IndustryMedical Devices
- CurrencyEUR
- Market capEUR 37.56M
- P/E13.7
- Financial periodFY2025
- RevenueEUR 15.73M
- Revenue growth10.2%
- Net incomeEUR 2.74M
- Free cash flow-EUR 1.36M
- Gross margin68.3%
Valuation Snapshot
latest market cap is EUR 37.56M; P/E is 13.7.
About Biohit Oyj B
Biohit Oyj, a biotechnology company, manufactures and sells bind acetaldehyde, diagnostic products, and systems for diagnostic analysis for the use of research institutions, healthcare, and industry worldwide. The company offers GastroPanel quick test NT, a rapid and quantitative immunochromatographic test for the detection of Helicobacter pylori and atrophic gastritis; GastroPanel test, a blood test for diagnosis of the function and structure of stomach mucosa;
Frequently asked questions
What is Biohit Oyj B's market cap?
Biohit Oyj B's market capitalization is EUR 37.56M.
What is Biohit Oyj B's P/E ratio?
Biohit Oyj B's price-to-earnings (P/E) ratio is 13.7.
What does Biohit Oyj B do?
Biohit Oyj, a biotechnology company, manufactures and sells bind acetaldehyde, diagnostic products, and systems for diagnostic analysis for the use of research institutions, healthcare, and industry worldwide.